Where are the approved GLP-1 injection sites?
Compounded semaglutide and tirzepatide are delivered subcutaneously — into the fat layer just beneath the skin. There are three sites where subcutaneous fat is reliably accessible for self-injection:
- Abdomen: The most commonly used site and the easiest to self-administer. Inject into the soft tissue of the lower or lateral abdomen, staying at least two inches away from the navel. The abdomen offers the largest rotation surface, which makes it the default starting point for most patients.
- Outer thigh: The anterolateral (front-outer) thigh provides good subcutaneous access. Avoid the inner thigh where the fat layer is thinner and the risk of accidental intramuscular injection is higher.
- Upper arm: The back of the upper arm (posterior tricep region) works but is harder to self-administer without a mirror. A household member or caregiver may be needed if this is your preferred site.
All three sites produce clinically acceptable absorption. The primary clinical recommendation is not which site you choose, but that you rotate consistently within and between sites.
| Site | Ease of self-injection | Rotation area | Key caution |
|---|---|---|---|
| Abdomen | Easiest | Largest (most rotation options) | Stay ≥2 inches from the navel |
| Outer thigh | Moderate | Moderate | Avoid inner thigh (thin fat layer, IM risk) |
| Upper arm | Hardest (may need assistance) | Smaller | Posterior tricep region only; avoid deltoid |
Why does rotating injection sites matter?
Subcutaneous injection is a mild but real tissue event. The needle puncture, the volume of fluid, and the pH of the solution all cause a small local inflammatory response. That is normal. What is not normal is allowing that response to accumulate in the same square centimeter week after week.
Repeated trauma to the same site leads to lipohypertrophy: a localized thickening of the subcutaneous fat caused by chronic mechanical irritation. You may notice a hard lump or rubbery patch of tissue. The problem is not just cosmetic. Lipohypertrophic tissue has impaired vascularity and altered tissue architecture — which slows and unpredictably delays medication absorption from that site.
Patients who develop lipohypertrophy often find that injections into the affected area feel less uncomfortable, which can inadvertently reinforce using the same spot. The tissue damage is masking normal sensation. This is the main reason rotation protocols are not optional.
Which of the three sites you pick matters far less than rotating between them — consistent rotation is what keeps absorption predictable dose after dose.
How do you rotate injection sites correctly?
Rotation has two dimensions: rotating within a site and rotatingbetween sites. Both matter.
Within-site rotation
Within any given site — say, the abdomen — each injection should land at least one inch (2.5 cm) from the previous injection and at least two inches from the navel. A simple mental grid helps: divide the abdomen into a clock-face and advance by two hours each week.
Between-site rotation
Switching between the abdomen, thigh, and arm gives any given patch of skin more recovery time. Many clinicians recommend a consistent weekly schedule — for example, left abdomen, right abdomen, left thigh, right thigh — so the pattern becomes automatic and is not re-negotiated each week.
What to record
Keep a brief log: date, site (left abdomen, right thigh, etc.), and any notable reactions. This is especially useful when troubleshooting nausea or absorption-related questions at your clinician check-in.
How do you inject a GLP-1 medication correctly? Step-by-step technique
Technique does not need to be elaborate, but it does need to be consistent. Follow your clinician’s specific instructions; these steps reflect general clinical guidance:
- Remove from refrigerator early: Allow the medication to reach room temperature for 5–10 minutes before injecting. Cold solutions from the refrigerator sting more and may slow absorption.
- Select and prepare the site: Choose your rotation site for this dose. Clean the area with an alcohol swab and let it dry fully before injecting.
- Confirm the dose: Draw up or verify the prescribed dose exactly as directed by your clinician before proceeding.
- Pinch if needed and insert at the correct angle: If you have adequate subcutaneous fat, insert at a 45–90 degree angle. If the fat layer is thin, a gentle pinch lifts tissue and reduces the risk of going intramuscular.
- Inject slowly and steadily: Rapid injection increases local pressure and can cause more discomfort and leakage.
- Remove and apply light pressure: Withdraw the needle at the same angle. Apply light pressure with a gauze pad. Do not rub the site.
- Dispose safely and log the injection: Place the used needle in a sharps disposal container and record the date, site, and any reactions.
Always follow the specific administration instructions provided by your prescribing clinician.
Additional technique notes:
- Temperature: Allow the medication to reach room temperature for 5–10 minutes before injecting. Cold solutions from the refrigerator sting more and may slow absorption.
- Skin prep: Clean the site with an alcohol swab and let it dry fully before injecting. Wet alcohol on the needle can sting and may slightly alter the injection environment.
- Pinch vs. no pinch: If you have adequate subcutaneous fat at the site, no pinch is needed — insert at a 45–90 degree angle depending on body composition. If the fat layer is thin, a gentle pinch lifts the tissue and reduces the risk of going intramuscular.
- Injection speed: Inject slowly and steadily. Rapid injection increases local pressure and can cause more discomfort and leakage.
- Post-injection: Do not rub the site. Light pressure with a gauze pad is fine. Rubbing can accelerate local dispersion in an unpredictable way.
What injection-site reactions should you watch for?
Most injection-site reactions are mild and resolve within a day or two. Redness, a small raised welt, or mild itching at the site is common in the first few weeks as the body adjusts. These reactions typically diminish with continued use.
Contact your prescribing clinician if you notice:
- A persistent lump or firm nodule at an injection site (possible lipohypertrophy)
- Signs of infection: increasing redness, warmth, swelling, or discharge
- Severe or expanding local reactions
- Bruising that extends beyond the immediate injection area
If your clinician prescribed compounded semaglutide or tirzepatide through PepScribe, your care team is available for check-in questions between scheduled visits. Use that channel — injection questions are exactly what it is for.
Frequently asked questions
What are the recommended GLP-1 injection sites?
The three primary subcutaneous GLP-1 injection sites are the abdomen (at least two inches from the navel), the outer thigh, and the upper arm. All three provide reliable subcutaneous fat tissue for absorption. Most clinicians start patients on the abdomen because it is easiest to self-administer and offers a large rotation area.
Does rotating GLP-1 injection sites matter?
Yes. Injecting repeatedly into the same small area can cause lipohypertrophy — a build-up of scar-like fatty tissue that slows absorption and makes dosing less predictable. Rotating within and between sites keeps tissue healthy and absorption consistent.
Can I inject GLP-1 in the same area every week?
Same general region is acceptable — for example, always the abdomen — but within that region each injection should land at least an inch from the previous site. The goal is to avoid building up tissue damage in any single spot.
Should the injection go into muscle or fat?
Subcutaneous (fat layer), not intramuscular. An intramuscular injection increases the speed of absorption unpredictably and can cause more local discomfort. Pinch the skin gently if you have less subcutaneous tissue to ensure you clear the muscle layer.
Does the injection site affect how well GLP-1 works?
Absorption rates can vary slightly between sites, but all approved subcutaneous sites provide clinically acceptable pharmacokinetics. The more important variable is consistency: rotating correctly within your chosen sites reduces absorption variability over time.
What should I do if I notice a lump or hard spot at an injection site?
Stop injecting into that area and let the tissue rest. Lumps are usually lipohypertrophy from repeated trauma. They typically resolve over weeks to months when the site is rested. Tell your clinician at your next check-in so they can assess the tissue and adjust your rotation pattern.